Infectious Diseases
Search for publications
Only original articles, editorials, guidelines.
-
Serre-Delcor N, Treviño B, Monge B, Salvador F, Torrus D, Guitérrez B, López-Vélez R, Soriano-Arandes A, Sulleiro E, Goikoetxea J, Pérez-Molina JA, Grupo de trabajo de +REDIVI.
Eosinophilia prevalence and related factors in travel and immigrants of the network +REDIVI.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 35(10): 617-623. Number of citations: 4
-
Serrano-Villar S, Hernández-Novoa B, de Benito A, Del Romero J, Ocampo A, Blanco JR, Masiá M, Sendagorta E, Sanz G, Moreno S, Pérez-Molina JA.
Screening for precancerous anal lesions with P16/Ki67 immunostaining in HIV-infected MSM.
Plos One . 12(11): . Number of citations: 10
-
López-Sanromán A, Rodríguez de Santiago E, Cobo Reinoso J, Del Campo Moreno R, Foruny Olcina JR, García Fernández S, García García de Paredes A, Aguilera Castro L, Ferre Aracil C, Albillos Martínez A.
Results of the implementation of a multidisciplinary programme of faecal microbiota transplantation by colonoscopy for the treatment of recurrent Clostridium difficile infection.
GASTROENTEROLOGIA Y HEPATOLOGIA . 40(9): 605-614. Number of citations: 2
-
Palacios-Baena ZR, Gutiérrez-Gutiérrez B, Calbo E, Almirante B, Viale P, Oliver A, Pintado V, Gasch O, Martínez-Martínez L, Pitout J, Akova M, Peña C, Molina Gil-Bermejo J, Hernández A, Venditti M, Prim N, Bou G, Tacconelli E, Tumbarello M, Hamprecht A, Giamarellou H, Almela M, Pérez F, Schwaber MJ, Bermejo J, Lowman W, Hsueh PR, Paño-Pardo JR, Torre-Cisneros J, Souli M, Bonomo RA, Carmeli Y, Paterson DL, Pascual Á, Rodríguez-Baño J, Spanish Network for Research in Infectious Diseases (REIPI)/European Study Group.
Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum ß-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort.
CLINICAL INFECTIOUS DISEASES . 65(10): 1615-1623. Number of citations: 35
-
Vena A, Muñoz P, Padilla B, Valerio M, Sanchez MI, Puig-Asensio M, Fortun J, Fernandez-Ruiz M, Merino P, Losa JE, Loza A, Rivas RA, Bouza E, CANDIPOP Project, GEIH-GEMICOMED (SEIMC), and REIPI.
Is routine ophthalmoscopy really necessary in candidemic patients?
Plos One . 12(10): . Number of citations: 26
-
Asmuth DM, Thompson CG, Chun TW, Ma ZM, Mann S, Sainz T, Serrano-Villar S, Utay NS, Garcia JC, Troia-Cancio P, Pollard RB, Miller CJ, Landay A, Kashuba AD.
Tissue Pharmacologic and Virologic Determinants of Duodenal and Rectal Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution in HIV-Infected Patients Initiating Antiretroviral Therapy.
JOURNAL OF INFECTIOUS DISEASES . 216(7): 813-818. Number of citations: 9
-
Norman FF, López-Polín A, Salvador F, Treviño B, Calabuig E, Torrús D, Soriano-Arandes A, Ruíz-Giardín JM, Monge-Maillo B, Pérez-Molina JA, Perez-Ayala A, García M, Rodríguez A, Martínez-Serrano M, Zubero M, López-Vélez R.
Imported malaria in Spain (2009-2016): results from the +REDIVI Collaborative Network.
MALARIA JOURNAL . 16(1): 407-407. Number of citations: 18
-
Sánchez-Del Cojo M, López-Huertas MR, Díez-Fuertes F, Rodríguez-Mora S, Bermejo M, López-Campos G, Mateos E, Jiménez-Tormo L, Gómez-Esquer F, Díaz-Gil G, Alcamí J, Coiras M.
Changes in the cellular microRNA profile by the intracellular expression of HIV-1 Tat regulator: A potential mechanism for resistance to apoptosis and impaired proliferation in HIV-1 infected CD4+ T cells.
Plos One . 12(10): . Number of citations: 13
-
Ghosn J, Bayan T, Meixenberger K, Tran L, Frange P, d'Arminio Monforte A, Zangerle R, de Mendoza C, Krastinova E, Porter K, Meyer L, Chaix ML, CASCADE Collaboration in EuroCoord.
CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus.
The Journal of antimicrobial chemotherapy . 72(10): 2862-2868. Number of citations: 3
-
San-Juan R, Pérez-Montarelo D, Viedma E, Lalueza A, Fortún J, Loza E, Pujol M, Ardanuy C, Morales I, de Cueto M, Resino-Foz E, Morales-Cartagena MA, Fernández-Ruiz M, Rico A, Romero MP, Fernández de Mera M, López-Medrano F, Orellana MÁ, Aguado JM, Chaves F.
Pathogen-related factors affecting outcome of catheter-related bacteremia due to methicillin-susceptible Staphylococcus aureus in a Spanish multicenter study.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES . 36(10): 1757-1765. Number of citations: 8
-
Crespo M, Navarro J, Moreno S, Sanz J, Márquez M, Zamora J, Ocampo A, Iribaren JA, Rivero A, Llibre JM.
Hepatic safety of maraviroc in HIV-1-infected patients with hepatitis C and/or B co-infection. The Maraviroc Cohort Spanish Group.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 35(8): 493-498. Number of citations: 2
-
Masiá M, Padilla S, Moreno S, Barber X, Iribarren JA, Del Romero J, Gómez-Sirvent JL, Rivero M, Vidal F, Campins AA, Gutiérrez F.
Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach.
Plos One . 12(9): . Number of citations: 5
-
Geretti AM, Loutfy M, D'Arminio Monforte A, Latysheva I, Pérez Elías MJ, Rymer J, Boffito M.
Out of focus: tailoring the cascade of care to the needs of women living with HIV.
HIV MEDICINE . 18 Suppl 2: 3-17. Number of citations: 7
-
Vivancos MJ, Gómez-Ayerbe C, Moreno S.
Highlights in HIV, 2016.
REVISTA ESPANOLA DE QUIMIOTERAPIA . 30 Suppl 1: 13-15.
-
Fortún J, Gioia F.
Invasive candidiasis in the neutropenic patient.
REVISTA ESPANOLA DE QUIMIOTERAPIA . 30 Suppl 1: 22-25. Number of citations: 4
-
Alpern JD, Lopez-Velez R, Stauffer WM.
Access to benznidazole for Chagas disease in the United States-Cautious optimism?
PLOS NEGLECTED TROPICAL DISEASES . 11(9): . Number of citations: 17
-
Pérez-Molina JA, López-Polín A, Treviño B, Molina I, Goikoetxea J, Díaz-Menéndez M, Torrús D, Calabuig E, Benito A, López-Vélez R.
6-year review of +Redivi: a prospective registry of imported infectious diseases in Spain.
JOURNAL OF TRAVEL MEDICINE . 24(5): . Number of citations: 28
-
Moreno Guillen S, Losa García JE, Berenguer Berenguer J, Martínez Sesmero JM, Cenoz Gomis S, Graefenhain R, Lopez Sanchez-Cambronero D, Parrondo Garcia FJ.
Cost-utility analysis of the fixed-dose combination of dolutegravir/abacavir/lamivudine as initial treatment of HIV+ patients in Spain.
FARMACIA HOSPITALARIA . 41(5): 601-610.